Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Mature B-cell Neoplasms × Lymphoid × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 501 Precursor Cell Lymphoblastic Leukemia-Lymphoma 469 Lymphoma, Non-Hodgkin 399 Lymphoma, Follicular 359 Leukemia, Lymphocytic, Chronic, B-Cell 355 Lymphoma, Large B-Cell, Diffuse 346 Lymphoma, B-Cell 225 Lymphoma, Mantle-Cell 204 Hodgkin Disease 188 Leukemia 185 Recurrence 180 Leukemia, Myeloid, Acute 177 Burkitt Lymphoma 167 Multiple Myeloma 162 Lymphoma, B-Cell, Marginal Zone 151 Neoplasms 135 Myelodysplastic Syndromes 120 Hematologic Neoplasms 101 Waldenstrom Macroglobulinemia 88 Lymphoma, T-Cell, Peripheral 78 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 77 Lymphoma, T-Cell 75 Lymphoma, T-Cell, Cutaneous 59 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 57 Mycosis Fungoides 53 Leukemia, Biphenotypic, Acute 49 Breast Neoplasms 48 Myeloproliferative Disorders 45 Leukemia, B-Cell 42 Lymphoproliferative Disorders 41

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05673460 2025-09-16

MK-1026-002

Merck Sharp & Dohme LLC

Phase 1 Completed

Mature B-cell Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡